ARCUTIS BIOTHERAPEUTICS INC's ticker is and the CUSIP is 03969K958. A total of 2 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92 | -57.6% | 17,400 | -23.7% | 0.00% | – |
Q2 2023 | $217 | +21600.0% | 22,800 | +22700.0% | 0.00% | – |
Q1 2023 | $1 | -100.0% | 100 | -83.3% | 0.00% | – |
Q3 2022 | $11,000 | -80.0% | 600 | -76.9% | 0.00% | – |
Q2 2022 | $55,000 | -64.7% | 2,600 | -67.9% | 0.00% | – |
Q1 2022 | $156,000 | +1850.0% | 8,100 | +1925.0% | 0.00% | – |
Q4 2021 | $8,000 | -69.2% | 400 | -60.0% | 0.00% | – |
Q3 2021 | $26,000 | -3.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $27,000 | +3.8% | 1,000 | +11011.1% | 0.00% | – |
Q1 2021 | $26,000 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 100 | $1 | 0.00% |